Countries Australia

Gencurix Receives Australian Government Approval for Droplex POLE Mutation Test

This test employs Droplet Digital PCP (ddPCR) technology to analyze POLE gene mutations in endometrial cancer patients, facilitating the detection of genet...

 October 12, 2023 | News

Monash University Sets Australian Standard with Groundbreaking Diabetes Precision Medicine Report.

In a significant development, a new international consensus report on precision medicine in diabetes prevention and care has been released in the renowned ...

 October 11, 2023 | News

Australia's First Cu-67 SAR-Bombesin Prostate Cancer Trial Patient Treated

  COMBAT, which derives from "Copper-67 SAR-Bombesin in metastatic castrate resistant prostate cancer (NCT05633160)1 is a dose escalation and co...

 October 04, 2023 | News

Bionomics Reports Positive Phase 2b Results for BNC210 in Post-Traumatic Stress Disorder Trial

ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant reduction in total PTSD symptom severity at 12 weeks. St...

 September 29, 2023 | News

Advanced Cancer Imaging Tool Streamlines Radiotherapy Adjustment for Doctors

An innovative technology that captures high-quality images of a tumor in six seconds is being used to guide cancer treatments for patients receiving care a...

 September 29, 2023 | News

Actinogen optimizes XanaMIA Phase 2b Alzheimer's disease trial design

Changes to the XanaMIA protocol reduce cost by AUD 30 million over the next two years and speed time to initial results while preserving the 36-week design...

 September 27, 2023 | News

Australia Launches National Study on Back and Neck Pain Risk Factors

The University of Adelaide's Experts Lead Landmark Australian Study on Back and Neck Pain A team of experts from the University of Adelaide is spearheadin...

 September 18, 2023 | News

Asia Pacific Nations Grapple with Plummeting Fertility Rates and Environmental Crisis, Urgent Actions Needed

Societies around the world are being confronted by inexorable evidence of falling fertility rates and environmental collapse that pose major threats to hum...

 September 08, 2023 | News

"Advancing Precision Oncology: Dr. Jerome Boyd-Kirkup Discusses Breakthroughs in HMBD-001 Trials"

In this exclusive interview with Dr. Jerome Boyd-Kirkup, Chief Scientific Officer of Hummingbird Bioscience, BioPharma APAC  delve into the recently i...

 September 06, 2023 | News

"Innovation Down Under: Exploring the Australian BioPharma Industry"

  Introduction Nestled on the vast, sunburned continent known for its stunning landscapes and unique wildlife, the Australian BioPharma industry has...

 September 05, 2023 | Analysis

Specialised Therapeutics acquires commercialisation rights to new oral MND therapy

ST to partner with Dutch biotech company Treeway BV  First CNS therapy in ST therapeutic portfolio   The therapy is known as TW001 and is a un...

 August 28, 2023 | News

Salvia BioElectronics Treats First Patient with Neuromodulation for Severe Migraine in Australia

The first patient, a 29-year-old woman from Australia who has suffered from debilitating headaches since the age of 14, experienced immediate and...

 August 24, 2023 | News

Inmagene Initiates POC Study for Extended Half-Life OX40 mAb in Atopic Dermatitis

IMG-007 is a humanized IgG1 monoclonal antibody (mAb) that specifically binds to the OX40 receptor. Its Fc region has been bioengineered, resulting in...

 August 16, 2023 | News

First Patient Dosed in Phase III Prostate Cancer Imaging Study of TLX591-CDx in China

  The Phase III Illuccix China study (ClinicalTrials.gov ID: NCT05847348) is a prospective, open-label, single-arm, multicenter study in Chinese...

 August 11, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close